We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

603260:SSEHoshine Silicon Industry Co. Ltd. Class A Analysis

Data as of 2026-03-12 - not real-time

CN¥48.85

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Hoshine Silicon trades at CNY 48.85, which sits above the DCF‑derived fair value of CNY 44.99, indicating the stock is currently overvalued. The company’s revenue has plunged 23.5% YoY and profit margins remain razor‑thin (gross margin 6.1%, operating margin 9.1%, net margin ‑0.16%), while its debt‑to‑equity ratio is a lofty 87.4, raising concerns about balance‑sheet strength. Technical signals are mixed: the price is below the 20‑day SMA (49.32) and 50‑day SMA (51.58), RSI sits at a neutral 45.5, but the MACD histogram has turned slightly positive, offering a modest bullish hint. Volume is stable and the stock sits comfortably above its support at CNY 47.16, yet the 30‑day volatility is high at 42.8% and the Fear & Greed Index reads “Extreme Greed”.
The dividend appears unsustainable, with a payout ratio exceeding 200% and a modest 0.92% yield. Forward earnings suggest a PE of 22.6, but the current earnings per share are negative, and analyst coverage is absent. Given the heavy debt load, weak profitability, and overvaluation, the outlook leans toward caution despite the sector’s long‑term growth potential in silicon‑based materials.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price above immediate support (CNY 47.16)
  • Bullish MACD histogram hint
  • Neutral RSI and overvaluation

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • High debt‑to‑equity ratio (87.4)
  • Negative trailing EPS and thin margins
  • Stock trading above DCF fair value

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Unsustainable dividend payout (>200%)
  • Fundamental weakness in revenue and profitability
  • Persistent overvaluation relative to intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth-23.50%
Profit Margin-0.16%
P/E Ratio22.6
ROE-0.19%
ROA0.12%
Debt/Equity87.37
P/B Ratio1.8
Op. Cash FlowCN¥6.4B
Free Cash FlowCN¥5.8B

Technical Analysis

TrendNeutral
RSI45.5
SupportCN¥47.16
ResistanceCN¥53.58
MA 20CN¥49.32
MA 50CN¥51.58
MA 200CN¥51.44
MACDBullish
VolumeStable
Fear & Greed Index76.14

Valuation

Fair ValueCN¥44.99
GradeOvervalued
TypeValue
Dividend Yield0.92%

Risk Assessment

Beta0.10
Volatility42.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.